author-photo

Saswati Hazra

Exelixis

3

Papers

36

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Quality-adjusted life years assessment using cabozantinib for patients with advanced hepatocellular carcinoma (aHCC) in the CELESTIAL trial.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (16)
Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (18)